Down another 6% in a week! So will the GSK share price ever recover?
The GSK share price has had a rotten few years and now it's heading south yet again. Investor Harvey Jones continues to hang ...
oncnursingnews2h
Early Switch to Atezolizumab After Vemurafenib/Cobimetinib Run-in Shows Improved Survival Trend in Melanoma
Earlier switch to atezolizumab after run-in with vemurafenib plus cobimetinib showed promise in improving OS rates in BRAF ...
devdiscourse3h
Regulatory Milestones and Health Advances: Key Developments in the Pharmaceutical Sector
Recent health news highlights key regulatory approvals and legal actions. The EU backs Novo Nordisk's Wegovy for an ...
Atlanta Daily World4h
HBCU Week Foundation To Host Its 8th Annual Event
The HBCU Week Foundation, a non-profit organization dedicated to supporting Historically Black Colleges and Universities (HBCUs), is thrilled to announce its 8th annual HBCU Week Wilmington (DE) ...
devdiscourse19h
Major Updates in Health: Drug Approvals, Legal Battles, and Health Innovations
Recent developments in health include EU approval of Novo's Wegovy for obesity-related heart conditions, the US FDA's nod for ...
WAPT22h
FDA approves first flu vaccine that can be self-administered at home
FluMist is a nasal spray manufactured by AstraZeneca that has been used to protect against influenza in the United States ...
US Federal Trade Commission Sues CVS Health, Cigna, UnitedHealth's Pharmacy Benefit Managers For Inflating Insulin Prices
On Friday, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers ...
At-home nasal spray flu vaccine to be available in fall of 2025
The FDA Friday approved the flu vaccine that can be done at home and does not need to be administered by a health care provider.
FDA approves at-home flu vaccine
The FDA is clearing the way for an at-home flu vaccines. A self-administered version of pharmaceutical giant AstraZeneca’s ...
No Doctor Necessary: US Okays Nasal Spray Flu Vaccine For Self-use
No doctor? No problem. In a first, the US Food and Drug Administration on Friday approved a nasal spray flu vaccine for self-administration. Starting next fall, AstraZeneca's FluMist, which was ...
In health breakthrough, FDA approves first nasal spray flu vaccine for at-home use
The U.S. Food and Drug Administration on Friday approved the first flu vaccine that comes in the form of a nasal spray and ...
Astrazeneca (AZN) Suffers a Larger Drop Than the General Market: Key Insights
The most recent trading session ended with Astrazeneca (AZN) standing at $78.38, reflecting a -0.66% shift from the previouse trading day's closing. The stock's change was less than the S&P 500's ...